Nelson HD, Tyne K., Naik A. et al. Screening for breast cancer: an update for the U. S. Preventive Services Task Force. JAMA. 2009;151:727-737.
2.
Zahl P.-H, Mæhlen J., Welch HGThe natural history of invasive breast cancers detected by screening mammography . Arch Intern Med. 2008;168:2311-2316.
3.
Andriole GL, Crawford ED, Grubb RL, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-1319.
4.
Schröder FH, Hugosson J., Roobol MJ, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomizedEuropean study. N Engl J Med. 2009;360:1320-1328.
5.
Steinwachs D. , Allen JD, Barlow WE, et al. National Institutes of Health State-of-the-Science Conference statement: enhancing use and quality of colorectal cancer screening . Ann Intern Med. 2010;152:663-667.
6.
Holden DJ, Jonas DE, Porterfield DS, Reuland D., Harris R.Systematic review: enhancing the use and quality of colorectal cancer screening . Ann Intern Med. 2010;152:668-676.
7.
Mysliwiec PA , Brown ML, Klabunde CN, Ransohoff DFAre physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141:264-271.
8.
Winawer SJ, Zauber AG, Fletcher RH, Stillman JSGuidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56:143-159.
9.
Imperiale TF , Sox HCGuidelines for surveillance intervals after polypectomy: coping with the evidence. Ann Intern Med. 2008;148:477-479.
10.
Morrell S., Barratt A., Irwig L., Howard K., Biesheuvel C., Armstrong B.Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control. 2010;21:275-282.
11.
Barratt A., Howard K., Irwig L., Salkeld G., Houssami N.Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330:936.
12.
U.S. Preventive Services Task Force recommendation statement.Screening for colorectal cancer. Ann Intern Med. 2008;149: 627-637.
13.
Kahi CJ, Rex DK, Imperiale TFScreening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology. 2008;135:380-399.
14.
Levin TR, Zhao W., Conell C., et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145:880-886.
15.
Saini SD, Nayak RS, Kuhn L., Schoenfeld P.Why don’t gastroenterologists follow colon polyp surveillance guidelines? Results of a national survey. J Clin Gastroenterol. 2009;43:554-558.
16.
Singh H., Turner D., Xue L., Tagrownik LE, Bernstein CNRisk of developing colorectal cancer after a negative colonoscopy examination. Evidence of a 10 year interval between colonoscopies. JAMA . 2006;295:2366-2373.
17.
Lakoff J., Paszat LF, Saskin R., Rabeneck L.Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008;6:1117-1121.
18.
Brenner H., Chang-Claude J., Seiler CM, Stürmer T., Hoffmeister M.Does a negative screening colonoscopy ever need to be repeated?Gut. 2006;55:1145-1150.
19.
Brenner H., Haug U., Arndt V., Stegmaier C., Altenhofen L., Hoffmeister M.Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology. 2010 ;138:870-876.
20.
Singh H., Nugent Z., Mahmud SM, Demers AA, Bernstein CNPredictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol. 2010;105:663-673.
21.
Imperiale TFFive year risk of intestinal neoplasia after negative screening colonoscopy. N Engl J Med. 2008;359:1218-1224.
